KCTD18 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.878330E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.055800E-01
Normal-vs-Stage2
1.222300E-02
Normal-vs-Stage3
8.708000E-02
Normal-vs-Stage4
5.397200E-01
Stage1-vs-Stage2
4.557200E-01
Stage1-vs-Stage3
7.535900E-03
Stage1-vs-Stage4
5.378800E-01
Stage2-vs-Stage3
5.955600E-02
Stage2-vs-Stage4
1.430240E-01
Stage3-vs-Stage4
1.170210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.483630E-02
Normal-vs-AfricanAmerican
1.137210E-01
Normal-vs-Asian
1.499360E-01
Caucasian-vs-AfricanAmerican
8.817800E-01
Caucasian-vs-Asian
8.795400E-01
AfricanAmerican-vs-Asian
8.498000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.353770E-02
Normal-vs-Female
3.582200E-02
Male-vs-Female
2.050400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.230850E-01
Normal-vs-Age(41-60Yrs)
3.220400E-02
Normal-vs-Age(61-80Yrs)
2.109700E-02
Normal-vs-Age(81-100Yrs)
2.373500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.889200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.365800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.114800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.270300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.311400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.853600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.356140E-02
Normal-vs-Daily Drinker
5.520300E-03
Normal-vs-Weekly Drinker
1.018580E-01
Normal-vs-Occasional Drinker
1.938360E-01
Normal-vs-Social Drinker
5.485900E-02
Non Drinker-vs-Daily Drinker
4.475200E-01
Non Drinker-vs-Weekly Drinker
7.423400E-01
Non Drinker-vs-Occasional Drinker
5.732100E-02
Non Drinker-vs-Social Drinker
3.607200E-01
Daily Drinker-vs-Weekly Drinker
3.917800E-01
Daily Drinker-vs-Occasional Drinker
1.663650E-02
Daily Drinker-vs-Social Drinker
1.239980E-01
Weekly Drinker-vs-Occasional Drinker
2.706200E-01
Weekly Drinker-vs-Social Drinker
7.017000E-01
Occasional Drinker-vs-Social Drinker
3.849800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.004100E-02
Normal-vs-Grade 2
1.276930E-03
Normal-vs-Grade 3
5.878700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.045400E-01
Grade 1-vs-Grade 3
3.766400E-01
Grade 1-vs-Grade 4
3.004100E-02
Grade 2-vs-Grade 3
3.012600E-01
Grade 2-vs-Grade 4
1.276930E-03
Grade 3-vs-Grade 4
5.878700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.003700E-02
Normal-vs-NonDiabetic
1.552440E-02
Diabetic-vs-NonDiabetic
5.685600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.178200E-02
Normal-vs-NoPancreatitis
1.741970E-02
Pancreatitis-vs-NoPancreatitis
6.312400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.344400E-02
Normal-vs-N1
1.232490E-02
N0-vs-N1
9.121800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.649900E-02
Normal-vs-TP53-NonMutant
8.500200E-02
TP53-Mutant-vs-TP53-NonMutant
8.645800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
